Abstract
BACKGROUND:
Value demonstration in health care remains a challenge. This
paper examines traditional approaches to pricing and the evolution of value-based
pricing (VBP), and proposes a new framework for evidence-based valuation (EBV).
The main objective of EBV is to estimate the value-based pricing range for the
new medicine, identify key product attributes that drive value as perceived by
various stakeholders, and then elucidate the requisite evidence to support
those value claims.
No comments:
Post a Comment